Arch Therapeutics



Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.

Richard E. Davis
Chief Financial Officer
Chirag B. Shah
VP of R&D Engineering & Quality Systems
Daniel C. Wadsworth, Jr.
VP of Dermal Sciences
Michael Abrams

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.